Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67591193
Product Categories
(Total 12 Products for Pf 04965842 Cas No 1622902 68 4)
Lorlatinib (PF-6463922) intermediate 99% CAS 1454848-00-0
Lorlatinib (PF-06463922) intermediates 99% CAS 1454848-00-0 Name: methyl(R)-2-(1-((2-amino-5-bromopyridin-3-yl)oxy)ethyl)-4-fluorobenzoate CAS: 1454848-00-0
Lorlatinib PF-6463922 intermediates CAS 1643141-20-1
Lorlatinib intermediates PF-06463922 CAS 1643141-20-1 Name: 1-methyl-3-((methylamino)methyl)-1H-pyrazole-5-carbonitrilehydrochloride salt CAS: 1643141-20
Lorlatinib intermediate PF-06463922 CAS 1454846-35-5
Lorlatinib intermediates PF-06463922 CAS 1454846-35-5 Lorlatinib (PF-6463922) is an anti-neoplastic drug for the treatment of non-small cell lung cancer. Name: PF-06463922, Lorlatinib CAS: 1454846-35-5
CAS NO.877399-52-5 Crizotinib 99.5%
High Purity Best Price CAS NO. 877399-52-5 Crizotinib Powder Crizotinib is a targeted therapy drug for non-small cell lung cancer developed by Pfizer Pharmaceuticals of the United States. The brand name is secure. Secure is a cutting-edge and epoch-making drug in the field of lung cancer targeted therapy. It was...
CAS No. 1110813-31-4 Dacomitinib (PF299804)
Dacomitinib (PF299804) is an effective, irreversible pan-erbb inhibitor that ACTS most effectively on EGFR, with an IC50 of 6nM, and efficiently on NSCLCs with EGFR or ERBB2 mutants (anti-gefitinib) and EGFRT790M mutants. Dacomitinib (PF299804), which name is (E)-N-[4-(3-chloro-4-fluoroanilino)-7-...
Dacomitinib (PF299804) CAS NO.1110813-31-4
Dacomitinib (PF299804) CAS NO.1110813-31-4 Pharmaceutical Grade : Product Name: Dacomitinib (PF299804) CAS No: 1110813-31-4 Appearence: Off-white to white powder Purity: 99%+
Molecular Formula:
Product Name Oclacitinib CAS No 1208319-26-9
Product Name Oclacitinib CAS No 1208319-26-9
99% Crizotinib CAS 877399-52-5
Crizotinib (trade name Xalkori, Pfizer) is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor, approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US and some other countries, and undergoing clinical trials testing its safety and efficacy in...
Crizotinib (trade name Xalkori, Pfizer) is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor, approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US and some other countries, and undergoing clinical trials testing its safety and efficacy in...
CAS NO.877399-52-5 Crizotinib 99.5%
High Purity Best Price CAS NO. 877399-52-5 Crizotinib Powder Crizotinib is a targeted therapy drug for non-small cell lung cancer developed by Pfizer Pharmaceuticals of the United States. The brand name is secure. Secure is a cutting-edge and epoch-making drug in the field of lung cancer targeted therapy. It was...
Pharmaceutical Crizotinib 877399-52-5
Product Description Crizotinib (trade name Xalkori, Pfizer) is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor, approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US and some other countries, and undergoing clinical trials testing its...
High Quality Products
Send Us a Message
We didn't put all products on website. If you can't find the product you're looking for, please contact us for more information.
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.